ES2215236T3 - Tratamiento con substancia p para inmunoestimulacion. - Google Patents

Tratamiento con substancia p para inmunoestimulacion.

Info

Publication number
ES2215236T3
ES2215236T3 ES97938049T ES97938049T ES2215236T3 ES 2215236 T3 ES2215236 T3 ES 2215236T3 ES 97938049 T ES97938049 T ES 97938049T ES 97938049 T ES97938049 T ES 97938049T ES 2215236 T3 ES2215236 T3 ES 2215236T3
Authority
ES
Spain
Prior art keywords
substance
treatment
immune
aerosols
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97938049T
Other languages
English (en)
Inventor
Mark L Witten
David T Harris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2215236T3 publication Critical patent/ES2215236T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A UNOS AEROSOLES DE SUSTANCIA P QUE SON EFICACES PARA RECONSTITUIR LOS SISTEMAS INMUNITARIOS COMPROMETIDOS POR SUSTANCIAS TOXICAS DEL MEDIOAMBIENTE. SON TAMBIEN UTILES PARA LA PROFILAXIS DE LAS INFECCIONES Y NEOPLASMAS, ASI COMO SU TRATAMIENTO. SON ADEMAS UTILES PARA ACELERAR LA MADURACION DE SISTEMAS INMUNITARIOS O TAMBIEN MANTENER LA FUNCION INMUNITARIA. LA EXPOSICION CRONICA A LOS HIDROCARBUROS ES ESPECIALMENTE PELIGROSA PARA EL SISTEMA INMUNITARIO, Y POR LO TANTO, SE PUEDE CONTRARRESTAR ESTE RIESGO PROFESIONAL MEDIANTE UN TRATAMIENTO CON AEROSOLES DE SUSTANCIA P.
ES97938049T 1996-07-23 1997-07-08 Tratamiento con substancia p para inmunoestimulacion. Expired - Lifetime ES2215236T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2206396P 1996-07-23 1996-07-23
US08/829,445 US5945508A (en) 1996-07-23 1997-03-28 Substance P treatment for immunostimulation

Publications (1)

Publication Number Publication Date
ES2215236T3 true ES2215236T3 (es) 2004-10-01

Family

ID=26695449

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97938049T Expired - Lifetime ES2215236T3 (es) 1996-07-23 1997-07-08 Tratamiento con substancia p para inmunoestimulacion.

Country Status (8)

Country Link
US (2) US5945508A (es)
EP (1) EP0957930B1 (es)
AT (1) ATE262342T1 (es)
AU (1) AU737201B2 (es)
CA (1) CA2261885A1 (es)
DE (1) DE69728294T2 (es)
ES (1) ES2215236T3 (es)
WO (1) WO1998003194A2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573244B1 (en) * 1999-05-17 2003-06-03 The United States Of America As Represented By The Secretary Of The Army Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
DE60139874D1 (de) * 2000-07-28 2009-10-22 Christopher J Murphy Medium für transplantat
IT1317895B1 (it) * 2000-08-10 2003-07-15 Univ Napoli Federico Ii Pseudo-metalloproteine, loro preparazione e loro uso.
WO2002102835A2 (en) * 2000-11-21 2002-12-27 New England Medical Center Novel antimicrobial compounds
US6437093B1 (en) * 2000-11-28 2002-08-20 Milkhaus Laboratory, Inc. Methods of treatment comprising administration of Substance P
CA2496447A1 (en) * 2002-08-27 2004-03-11 Mark L. Witten Amelioration of effects of cigarette smoke
AU2003293582A1 (en) * 2002-12-18 2004-07-22 Mark L. Witten Stimulation of hair regrowth
WO2004091649A1 (en) * 2003-04-14 2004-10-28 Immuneregen Biosciences, Inc. Acute respiratory syndromes
US20070207209A1 (en) * 2004-08-27 2007-09-06 Murphy Christopher J Trophic factor combinations for nervous system treatment
CA2580694A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
EP1809313A4 (en) * 2004-10-27 2008-01-23 Immuneregen Biosciences Inc PROCESS FOR PROMOTING WOUND HEALING
KR100593397B1 (ko) * 2004-10-27 2006-06-28 한국원자력연구소 중배엽 줄기세포 및/또는 ｐ 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
SG123646A1 (en) * 2005-01-05 2006-07-26 Immuneregen Biosciences Inc Prevention of respiratory infections in fowl
CA2594517A1 (en) * 2005-01-12 2006-07-20 Immuneregen Biosciences, Inc. Treatment of skin diseases
SG126014A1 (en) * 2005-04-01 2006-10-30 Immuneregen Biosciences Inc Treatment of asthma
US20060281670A1 (en) * 2005-06-10 2006-12-14 Wisconsin Alumni Research Foundation (Warf) Compositions and methods for modulating angiogenesis
WO2007062060A2 (en) 2005-11-22 2007-05-31 Ted Reid Methods and compositions using substance p to promote wound healing
US20090137492A1 (en) * 2006-03-10 2009-05-28 Immuneregen Biosciences, Inc. Method to reduce the risk and/or severity of anthrax infection
WO2008036157A2 (en) * 2006-08-15 2008-03-27 Immuneregen Biosciences, Inc. Prophylactic and therapeutic treatment of avian influenza infections in animals
WO2008088846A2 (en) * 2007-01-18 2008-07-24 Immuneregen Biosciences, Inc. Substance p and analogs thereof as an immunogenic composition adjuvant
US8321012B2 (en) 2009-12-22 2012-11-27 The Invention Science Fund I, Llc Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5410019A (en) * 1987-09-24 1995-04-25 The Administrators Of The Tulane-Educational Fund Therapeutic peptides
US5256765A (en) * 1989-03-09 1993-10-26 The Johns Hopkins University School Of Medicine Biodegradable poly(phosphate esters)
JPH06510752A (ja) * 1991-05-24 1994-12-01 ノースウエスタン・ユニバーシティ アレルギー治療のためのｐ物質の使用方法
EP0545478A1 (en) * 1991-12-03 1993-06-09 MERCK SHARP & DOHME LTD. Heterocyclic compounds as tachykinin antagonists
ATE206710T1 (de) * 1994-06-06 2001-10-15 Warner Lambert Co Tachykinin (nk1) rezeptor antagonisten

Also Published As

Publication number Publication date
US5945508A (en) 1999-08-31
ATE262342T1 (de) 2004-04-15
US5998376A (en) 1999-12-07
EP0957930B1 (en) 2004-03-24
WO1998003194A3 (en) 1998-06-18
WO1998003194A2 (en) 1998-01-29
CA2261885A1 (en) 1998-01-29
DE69728294T2 (de) 2004-08-19
EP0957930A2 (en) 1999-11-24
AU737201B2 (en) 2001-08-09
AU4046497A (en) 1998-02-10
DE69728294D1 (de) 2004-04-29

Similar Documents

Publication Publication Date Title
DE69728294D1 (de) Substance p behandlung zur immunostimulierung
EA200001245A1 (ru) КОМПОЗИЦИИ НА ОСНОВЕ ПИРРОЛО [2,3d] ПИРИМИДИНОВ И ИХ ПРИМЕНЕНИЕ
AR003426A1 (es) Derivados de rapamicina y procedimiento para prepararlos, composiciones farmacéuticas formuladas con dichos derivados y equipos(kits) que incluyen dichos derivados para tratar infecciones,estados inflamatorios o tratamientos inmunosupresores.
TR200001023T2 (tr) Alfa-aril-N-Alkilnitronlar ve onları içeren farmasötik kompozisyonlar.
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
ES2174895T3 (es) Combinaciones metalicas complejas con contenido en carbenos heterociclicos.
MX9302011A (es) Derivados de indol.
NL181818C (nl) Schroef met een kruisvormige uitsparing in de kop, alsmede schroevedraaier voor toepassing bij zo'n schroef en pons voor het vormen van de uitsparing.
BR9707081A (pt) Soluções de injeção e infusão concentradas aperfeiçoadas para aplicação intravasal
TR200000374T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavbeta6 antagonistleriyle tedavisi.
MX173963B (es) Sujetador roscado autosellante y proceso para elaborar el mismo.
SE9504331D0 (sv) Method of adding particulate additives to metal prticles
BG101105A (bg) Заместени бензамидини, тяхното получаване и използването им като лекарствени средства
PT100123A (pt) Processo para acabamento de madeiras ambientalmente seguro e composicao para o tratamento de superficies de madeira
ES2090329T3 (es) Sistemas de aditivos en forma solida dispersables en medios acuosos.
NL181933B (nl) Samenstelling en werkwijze voor het maskeren van krassen op glazen voorwerpen; behandelde glazen voorwerpen.
ATE162794T1 (de) Schrittweise entfernung von monosacchariden vom reduzierenden ende von oligosacchariden und verwendungen davon
BG100248A (bg) Инхибитори на скваленсинтетаза
DE59309740D1 (de) Lyopilisierte, wirkstoffhaltige emulsion
BR9102075A (pt) Composicao contendo um elastomero,processo para estabilizar elastomero e aplicacao
NL1000138C2 (nl) Inrichtingen voor het bewerken van een substraat alsmede werkwijze geschikt voor toepassing bij dergelijke inrichtingen.
NZ511467A (en) Method for preventing and reversing atherosclerosis in mammals
BR9203332A (pt) Composicao absorvedora de ruidos para sistema de suspensao de compressores,motores e dispositivos similares
NO913502L (no) Kompositt for anvendelse som hoeyenergi-sprengstoff eller drivmiddel.
DE69329166D1 (de) Silikonadditivsysteme